29.91
+0.36
(1.22%)
May 23 - Close
SHA
real-time data -
Disclaimer
Currency in CNY
| Range | 29.39 - 29.96 |
| 52 week | 25.22 - 35.20 |
| Open | 29.61 |
| Vol. | 12.54M |
| Mkt cap | 36.99B |
| P/E | 34.33 |
| EPS | 0.87 |
| Shares | 1.24B |
Events
Aug 5, 2013
Q2 2013 Jiangsu Hengrui Medicine Co Ltd Earnings Release
Apr 26, 2013
Q1 2013 Jiangsu Hengrui Medicine Co Ltd Earnings Release
Apr 25, 2013
恒瑞医药：第六届监事会第一次会议决议公告
Apr 25, 2013
恒瑞医药：2012年度股东大会决议公告
Apr 25, 2013
恒瑞医药：独立董事关于高级管理人员提名及聘任程序的独立意见
Apr 25, 2013
恒瑞医药：2013年第一季度报告
Apr 25, 2013
恒瑞医药：第六届董事会第一次会议决议公告
Apr 25, 2013
恒瑞医药：2012年年度股东大会的法律意见书
Apr 23, 2013
Jiangsu Hengrui Medicine Co Ltd Annual Shareholder Meeting
Apr 17, 2013
Q4 2012 Jiangsu Hengrui Medicine Co Ltd Earnings Online Presentation (Mandarin)
|
|
Key stats and ratios
| Q4 (Dec '12) | 2012 | |
| Net profit margin | 21.26% | 21.18% |
| Operating margin | 20.35% | 23.92% |
| EBITD margin | - | 25.39% |
| Return on average assets | 20.68% | 21.50% |
| Return on average equity | 21.58% | 22.83% |
| Employees | 8,267 | - |
| Carbon Disclosure Rating | - | - |
Address
No. 145 Renmin East Road Xinpu District
LIANYUNGANG, JNG 222000
China
+86-518-85469805 (Phone)
+86-518-85453845 (Fax)
LIANYUNGANG, JNG 222000
China
+86-518-85469805 (Phone)
+86-518-85453845 (Fax)
Website links
External links
Discussion Group - Google Finance
Advertisement
Description
JIANGSU HENGRUI MEDICINE CO., LTD. is principally engaged in the manufacturing and distribution of pharmaceutical tablets, injections and raw materials. The Company is also involved in medicine commerce. The Company mainly provides antineoplastic drugs, drugs for the treatment of cardiovascular disease, drugs for surgery, drugs for the treatment of endocrine, antibiotics, big infusions and others, including calcium levofolinate for injection, cyclophosphamide for injection, etoposide for soft capsules, calcium folinate tablets, irbesartan tablets, bupivacaine hydrochloride for injection, levofloxacin hydrochloride tablets, glucose injections and sodium chloride injections, among others. The Company distributes its products primarily in domestic markets.
Officers and directors
| Piaoyang Sun | Chairman of the Board | |
| Xinhua Jiang | Vice Chairman of the Board | |
| Jieping Sun | Chief Financial Officer, Deputy General Manager | |
| Yunshu Zhou | General Manager, Director | |
| Hongbin Dai | Deputy General Manager, Secretary of the Board | |
| Lianshan Zhang | Deputy General Manager, Director | |
| Yongqiang Zhang | Deputy General Manager, Director | |
| Sumei Jiang | Deputy General Manager | |
| Jiang Liu | Deputy General Manager | |
| Lingjia Shen | Deputy General Manager |